From a therapeutic point of view, angiostatin cDNA coding from mouse angiostatin into murine T241 fibrosarcoma cells is able to inhibit angiogenesis and tumor growth in C57Bl6/J mice, confirming the role of neovascularization in this preclinical model [53]. This evidence concerns the gene PLG and neoplasm.